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Abstract
Background: Human enteroviruses have long been associated with various diseases of man resulting into a wide range of
acute symptoms involving the cardiac and skeletal muscles, central nervous system, pancreas, skin and mucous membranes.
Objective: To assess the role of  enteroviruses in the etiology of  hypertension, DCM and HHF.
Methods: We obtained stool specimens from 70 subjects comprising 65 patients and 5 controls and isolation was carried
out on RD, L20B, HEp-2C and Vero cell lines and identified by neutralization with standard antisera (RIVM). Thirty-six
enteroviruses were isolated and identified to be Coxsackieviruses-B5, A9, Echoviruses 1, 6, 7, 9, 11, 12, 22, 30 and Poliovirus
type 1 and 3.
Results: Three most frequently occurring enterovirus serotypes which constitute 60.0% of the 30 NPEV typed and 50.0%
of all the isolates were Echoviruses, Coxsackie-B5-virus and Coxsackievirus-A9. Echoviruses constituted 50.0% of all the
serotypes while Coxsackieviruses-B5 and A9 accounts for the 27.8 % and 5.6% respectively. Enteroviral isolation rate was
higher in age groups 51 years and above. The percentage of study subjects who had Coxsackie-B5-viruses and echoviruses
was significantly (P<0.05) higher in cases of hypertension, HHF and DCM than in control subjects. Coxackie-B5-virus,
Echovirus-6 and Echovirus-11 were found in both study locations.
Conclusion: The findings of this study showed that Enteroviruses may likely be involved in the etiology of hypertension,
DCM and HHF. Further studies would therefore be necessary for the prevention and control of  these diseases.
Keywords: Etiology, coxsackieviruses, Echoviruses, dilated cardiomyopathy (DCM), Enteroviruses, hypertension,
hypertensive heart failure (HHF).
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Human enteroviruses have long been associated with
various diseases of man resulting into a wide range
of acute symptoms involving the cardiac and skeletal
muscles, central nervous system, pancreas, skin and
mucous membranes1-2. Their roles in chronic diseases
such as the dilated cardiomyopathy, insulin –
dependent diabetes mellitus, motor neurone disease,
chronic fatique syndrome and postpoliomyelitis,
syndrome have also been documented3-8. Worldwide,
an estimated one billion infections occur each year9.
Enteroviruses (EVs), particularly the
Coxsackie B viruses, are cardiotropic and are
important causes of myopericarditis in children and
adults10,11 and are associated with the pathogenesis
of dilated cardiomyopathy12-13. Recent polymerase
chain reaction (PCR) studies in human myocardium
have provided evidence that enteroviral infection was
detectable in acute and chronic myocarditis, as well
as, in end-stage idiopathic dilated cardiomyopathy
(IDCM)10,13. Some, but not all, studies suggested that
positive PCR for virus may be an unfavourable
predictor, and it has been proposed that additional
prospective data are needed14. In a prospective study,
Heymans15 assessed aetiopathogenesis in myocarditis,
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including a positive PCR for virus and serum as viral
and autoimmune markers.
Previousstudies by Mahrholdt et al.16; Heymans et al.17;
Heymans15; Maekawa et al. 18 and Caforio et al.19 have
also shown that many viruses are capable of damaging
the heart during their replication which often causes
damage to the heart cells in 25-50% of all cases of
acute heart failure. Pauschinger et al.20 found 24 of
94 patients with IDCM leading to heart failure to have
either adenoviral or enteroviral polymerase chain
reaction positivity from clinical heart samples.
Cardiomyopathy been reported to be
associated with viruses like coxsackieviruses,
adenovirus, and echovirus. Enteroviruses and
adenoviruses have been considered the most common
pathogens of  viral cardiomyopathy, but parvovirus B19
(PVB19) is increasingly found in endomyocardial
biopsies of patients with  acute myocarditis or
IDCM16,21. Recent biopsy series in patients with DCM
have revealed that long-term persistence  of
cardiotropic viruses triggers heart failure at long term:
>70% of patients with DCM carry a cardiotropic virus
in the heart as reported by Tschope et al.22 and Kuhl et
al.23.
Isolation and identification of enteroviruses
is important to establish an etiologic/epidemiologic link
among cases during an outbreak and to recognize
serotype-specific cases, such as dilated cardiomyopathy
and hypertensive heart failures. Confirmation of  a
suspected enterovirus infection is important for
management of patient, prognosis, reducing
hospitalization, preventing outbreaks, and excluding
other infectious diseases, and therefore prevents
unprescribed antibiotic usage. In addition, rapid
confirmatory diagnosis of  enteroviral infections could
facilitate use of the novel antiviral drugs, such as
pleconaril, targeted at the Picornaviridae24-26. However,
the impact of the endemic enteroviral infection on
the cardiovascular system in Africans has received
scanty attention by researchers. There is, however,
dearth of literatures on the precise role or contributions
of enteroviruses in the pathogenesis of DCM and
HHF in Nigeria. Thus, this study attempted to isolate
and identify enteroviruses as a possible cause of




All of the patients used for this study came from Ibadan
city in Oyo state, one of the largest city in Africa and
its immediate environs and few were from Abeokuta
and its envirions both in South- Western, Nigeria.
Study Population
Informed consent was obtained from each patient
before investigations were carried out. A total of
seventy (70) subjects (comprising 65 patients and 5
controls) were selected for studies based on M-mode
echocardiography (ages 4-83 years; mean age: 49.7
years). The 65 study subjects comprised 48 (73.8%)
males and 17(26.2%) females (Table 3) while the
control groups comprised 4(80.0%) males and
1(20.0%) female (Table 4). The study subjects were
so confirmed of  the clinical condition by the
Consultant Cardiologists. The control subjects were
also so confirmed free of  the clinical conditions.
Demographic and clinical information of  the subjects
were obtained by chart abstraction and recorded on a
prepared data collection form. Other relevant
information such as socio-economic status, occupation,
history of smoking and alcohol intakes and parity
(females only) were obtained using a Performa specially
designed for this purpose.
Sample collection
Stool samples were collected aseptically from the
subjects (65 patients and 5 controls) and the laboratory
investigation such as viral isolation and identification
carried out according to standard laboratory
procedures of WHO manual28. All specimens were
collected aseptically and transported in cold chain. The
70 samples from 65 patients and 5 controls were
analyzed anonymously, as required by ethical rules27.
Specimens preparation for virus isolation
All stool samples were treated with chloroform before
inoculation into cell culture28.
Cell lines and tissue culture media
Green monkey kidney (Vero), human epidermoid
carcinoma (HEp-2) and human rhabdomyosarcoma
(RD), and genitically engineered mouse cell (L20B)
lines were used in this study28. With adherence to aseptic
procedures and WHO28 protocols, cells seeded into
test tubes and at specified cell concentrations. Cell lines
were cultured in Eagle’s minimum essential medium
with Earle’s salts (Gibco, Invitrogen, Paisley, UK/
Gibco, BRL, Grand Island, N.Y.) supplemented with
5% /10% fetal bovine serum, 2 mM Lglutamine, 26.8
mM NaHCO3, 100 U of penicillin per ml, and 100g
of streptomycin per ml and amphotericin B [0.25g/
ml]). All tissue culture media and reagents were
composed and prepared according to the working
African Health Sciences Vol 13  Issue 4 December  20131100
standard method described by WHO28 for the virologic
investigation of  enteroviruses.
Virus isolation
Virus isolation and in vitro propagation was carried out
using Vero, HEp-2, RD and L20B and all processed
stool samples were inoculated onto monolayers of these
four different cell lines and incubated in the stationary
sloped position at 37°C. The cultured tubes were
observed daily, using a standard/inverted microscope,
for appearance of cytopathic effect (CPE)
characteristic for enterovirus for the first 7 days; day
10 and finally at 14 days post-inoculation as described
by WHO28.
Virus identification
Poilo and NPEVs isolated in this study were identified
using specific polyclonal antisera as described by the
WHO28 standard protocols for identifications of polio
and non-polio enteroviruses.
Antisera
Pooled horse antisera against the most frequently
isolated ECHO and Coxsackieviruses were provided
by the National Institute of Public Health and the
Environment (RIVM), Bilthoven, The Netherlands.
Interpretation of the results was done with the
assistance of a list of the neutralization patterns of
individual viruses28.
Identification by Neutralization Assay
Identification of  virus serotypes was performed by
neutralization test using type-specific antisera (National
Institute of Public Health and the Environment, The
Netherlands) as described by WHO28.
Virus titration
Virus titre was determined by measuring TCID
50
 of
each virus isolate in RD cells, as previously described28.
Results
Virus isolations
A total of 36 isolates belonging to 10 clearly defined
enterovirus serotypes were recovered from samples
collected from the subjects confirmed to be DCM
and HHF. One of  the 36 isolates was recovered from
the control group. The cell line of  the positive samples
showed cellular degeneration as cytopathic effect (CPE)
which was very rapid, becoming 4+ in 1-3 days with all
cells detached from the glass base. CPE for the
remaining enteroviruses generally requires 4-7 days
or longer and often accompanied by individual small,
round, and sometimes refractile cells or by a
degenerative appearance across the monolayer, and
might not progress to 4+ or general cell lysis. CPE for
the remaining were not specific for enteroviruses and
were not tested further.
Virus typing and identification
Table 1 shows the frequency of  enteroviruses among
the various studied groups. The 10 serotypes were
identified as Coxsackie-B5-viruses [10 (27.8%)],
echovirus 6 and 11 [4 (11.1%) each], echovirus 7, 9,
12, and 30 [2 (5.6%) each], Coxsackievirus A9
[2(5.6%)], poliovirus (PV) type 1 [2(5.6%)], PV3
[2(5.6%)] and mixture of PV1 and PV3 [2(5.6%)],
and echovirus 1 and 22 [1 (2.8%) each] as shown in
table 1.
Table 1: Frequency of  Occurrence of  Enteroviral Isolates






Coxsackie-B5-virus 10  (27.8) + - + +
Echovirus 7 2   (5.6) + - - +
Echovirus 11 4 (11.1) + - + +
Echovirus 9 2   (5.6) + - - +
Echovirus 6 4 (11.1) + - + +
Coxsackievirus-A9 2   (5.6) + - + +
Echovirus 1 1   (2.8) + - + -
Echovirus 22 1   (2.8) + - + -
Echovirus 12 2   (5.6) + - + +
Echovirus 30 2   (5.6) + - - +
Poliovirus 1 (PV1) 2   (5.6) + - + +
Poliovirus 3 (PV3) 2   (5.6) + - + +
PV1+PV3Mixtures 2   (5.6) + + + +
Total 36 (100.0) 35(97.2) 1(2.8) 7(19.4) 29(80.6)
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Distribution of Enterovirus Isolates in relation
to the group studied
Table 2 shows the distribution of  enterovirus isolates
in relation to patient groups studied. It showed that
enteroviral infection was most prevalent among study
subjects with DCM [26(63.4%)], followed by
hypertensives [8(40.0%)], and HHF [1(25.0%)].
However, one (20.0%) of the controls was positive
for enterovirus.
Distribution of Enterovirus Isolates in relation
to Location of study
Table 3 shows distribution of  enterovirus isolates in
relation to locations of  study. It showed that
enteroviral infection was more prevalent among
subjects at FMC, Abeokuta [6(60.0%)] than their
counterparts at UCH, Ibadan [29(52.7%)]. It also
showed that 1(50.0%) of the two controls from
Abeokuta was positive for enterovirus (table 3).












Normotensives 0(0.0) 0(0.0) Normotensives 5(100.0) 1(20.0)
Hypertensives 20(30.8) 8(40.0) Hypertensives 0(0.0) 0(0.0)
Hypertensive Heart 
failure 
4(6.2) 1(25.0) Hypertensive Heart failure 0(0.0) 0(0.0)
Dilated Cardiomyopathy 41(63.1) 26(63.4) Dilated Cardiomyopathy 0(0.0) 0(0.0)
Total 65(100.0) 35 (53.8) Total 5(100.0) 1 (20.0)
Table 3: Distribution of  Enterovirus isolates in relation to locations studied









Distribution of Enterovirus Isolates in relation
to various risk factors and demographics of
subjects
Table 4 shows the distribution of  enterovirus isolates
in relation to various risk factors and demographics
of  study subjects. It showed that enteroviral infection
was more prevalent among ages 51 years and above
[19(54.3%)] compared to their counterparts in ages
below 51 years [16(53.3%)]. However, this difference
was not statistically significant (p>0.05). The
distribution of enteroviruses in relation to sex is
shown in table 4. It showed that enteroviral infection
was more prevalent among males [27(56.3%)]
compared to their female counterparts [8(47.1%)].
The results showed that the enterovirus isolates
occurred frequently among the low-income class
subjects (73.5%) and high-income class subjects
(60.0%) compared to their counterparts in the 4
member-middle class (19.0%). There was a significant
difference in the rate of enteroviral infection between
subjects in the high and the low socio-economic
groups (p<0.05).
Enteroviral isolates were more prevalent
among farmers (100.0%). This was followed by
businessmen and unemployed subjects (66.7% each),
traders (61.0%), civil servants (60.0%), students
(57.1%), clergy, custom officer and pensioners (50.0%
each). Enteroviral isolates were least prevalent among
professionals (25.0%) while no enterovirus isolates
was obtained from the teachers studied (table 4).
From table 4, it showed that enteroviral
infection was highest among subjects with history
of heart failure (63.4%), hypertension (56.1%), DCM
(61.0%), alcoholics (73.3%), smoking (75.0%), and
multiparious females (66.7%) compared to their
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counterparts without such history. Females with no
history of pregnancy (nulliparious) had the least
enteroviral infection rate (12.5%). There was a
significant association (p<0.05) between the rate of
enterovirus infection and clinical history of subjects
(table 4). Statistically, enterovirus isolation rate was
significantly (p<0.05) higher in those with
hypertension, DCM and HHF than those in the
control group (table 4).
Table 4 shows the distribution of
enterovirus isolates in relation to various risk factors
and demographics of  control subjects. It showed
that enteroviral infection was only found among male
control subject age 51 years and above [1(25.0%)].
The control results also showed that the enterovirus
isolates occurred only among the low-income class
and a farmer (table 4). Statistically, enterovirus
isolation rate was significantly (p<0.05) higher in the
study group than the control group (table 4).
Table 4: Distribution of  Enterovirus Isolates in relation to Risk factors among the study groups









Below 51 30(44.6) 16(53.3) 1(20.0) 0(0.0)
51 and above 35(55.4) 19(54.3) 4(80.0) 1(25.0)
Gender
Male 48(73.8) 27(56.3) 4(80.0) 1(25.0)
Female 17(26.2) 8(47.2) 1(20.0) 0(0.0)
Clinical History
History of Heart Failure 
Yes 41(63.1) 26(63.4) 0(0.0) 0(0.0)
No 24(36.9) 9(37.5) 5(100.0) 1(20.0)
History of Hypertension
Yes 41(63.1) 23(56.1) 0(0.0) 0(0.0)
No 24(36.9) 12(50.0) 5(100.0) 1(20.0)
History of DCM
Yes 41(63.1) 25(61.0) 0(0.0) 0(0.0)
No 24(36.9) 10(41.7) 5(100.0) 1(20.0)
History of Alcohol
Yes 15(23.1) 11(73.3) 0(0.0) 0(0.0)
No 50(76.9) 24(48.0) 5(100.0) 1(20.0)
History of Smoking
Yes 12(18.5) 9(75.0) 0(0.0) 0(0.0)
No 53(81.5) 26(49.0) 5(100.0) 1(20.0)
Parity (Females; n=17)
Below 4   4(23.5) 2(50.0) 0(0.0) 0(0.0)
Multiparity (4 and above) 6(35.3) 4(66.7) 0(0.0) 0(0.0)
Nulliparity 7(41.2) 1(14.3) 1(100.0) 0(0.0)
Socio-economic Class
High Income Class   10(15.4) 6(60.0) 0(0.0) 0(0.0)
Middle Income Class 21(32.3) 4(19.0) 3(60.0) 0(0.0)
Low Income Class 34(52.3) 25(73.5) 2(40.0) 1(50.0)
Occupations 
Students 7(10.8) 4(57.1) 2(40.0) 0(0.0)
Farmers 2(3.1) 2(100.0) 0(0.0) 0(0.0)
Traders 23(35.4) 14(61.0) 2(40.0) 1(50.0)
Civil servants 10(15.4) 6(60.0) 1(20.0) 0(0.0)
Pensioner 2(3.1) 1(50.0) 0(0.0) 0(0.0)
Businessmen 3(4.6) 2(66.7) 0(0.0) 0(0.0)
Teachers 3(4.6) 0(0.0) 0(0.0) 0(0.0)
Custom officer 2(3.1) 1(50.0) 0(0.0) 0(0.0)
Professionals 8(12.3) 2(25.0) 0(0.0) 0(0.0)
Clergy 2(3.1) 1(50.0) 0(0.0) 0(0.0)
Unemployed 3(4.6) 2(66.7) 0(0.0) 0(0.0)
Total 65(100.0) 35(53.8) 5(100.0) 1(20.0)
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Discussion
This study examined stool samples of hospital
inpatients and outpatients with hypertension,
Hypertensive heart failure (HHF), and dilated
cardiomyopathy (DCM). Subjects with normal
blood pressure were used as control. The study
showed that enterovirus isolation rate was significantly
(p<0.05) higher in those with hypertension, DCM
and HHF than those in the control group. Among
the enteroviruses isolated, echoviruses and Coxsackie-
B5-viruses were the most implicated. Enteroviral
infection is thought to be the most common cause
of HHF and DCM leading to heart failure. Many
studies have evaluated the role of enterovirus
infections (particularly Coxsackieviruses B4 and B5)
as environmental triggers of  diseases. Several lines
of  evidence also suggested that enterovirus infections
may be involved in the etiology of  the dilated
cardiomyopathy (DCM) leading to heart failure and
hypertensive heart failures11-13, 29-31.
The pattern of distribution of each of the
10 identified NPEV serotypes differs in each of the
2 location studied with Coxsackie-B5-virus,
Coxsackievirus A9, Echoviruses 1, 6, 9, 11, 12, 22
and 30, as well as, Polioviruses present in the 2
locations studied. Echoviruses 7, 9 and 30 were
isolated only from patients in Ibadan. The findings
of  this present study suggest that enteroviruses are
endemic in Nigeria and the frequency of occurrence
among this patients studied is higher compare to
other studies32-37. Previous study in Nigeria suggested
that Coxsackievirus B infections have been associated
with clinical manifestation of DCM and HHF4. Muir
et al.30 reported a significantly higher prevalence of
enterovirus-specific IgM responses among patients
with DCM.
The three most frequently occurring
enterovirus serotypes which constitute 60.0% of the
30 NPEV typed and 50.0% of all the isolates were
Echoviruses, Coxsackie-B-viruses and
Coxsackievirus A9. Coxackie-B5-virus was found
in the two study locations in Ibadan and Abeokuta.
Echovirus-6 and 11 was also found in both locations.
Statistically, enterovirus isolation rate was significantly
(P<0.05) higher in the study group than the control
group. Occurrence of  echovirus-6 was also
documented as localized in Spain38, while both
echovirus-6 and 11 had been implicated in an
outbreak of mixed enterovirus infections in Kansas
City39. In a study by Li et al.11, nine of 14 myocardial
samples from endemic DCM cases in China were
positive for the enteroviral RNA. The isolation of
echovirus 9 and 12 in this study deviates from the
findings of Adejokun36 who reported the absence
of  these two serotypes in their study.
The isolation of Enteroviruses in this study
gives an indication that enteroviral infection may likely
have a role in the etiology of  the different diseases
studied. Our finding is similar to the work of Antia40
who found Coxsackievirus in the stool of one out
of five children with DCM who later developed
heart failure. It is also similar to Adejokun36 who
reported Coxsackie-B-virus, Coxackievirus A9,
echovirus 6, 7 and 11 in patients who presented with
DCM in Ibadan.
The study showed significant association
between the enteroviral infection and the socio-
economic status of  the subjects. The presence of
these enteroviruses in the subjects were not surprising,
it may have been probably due to over-crowding,
poor sewage disposal and poor living standard
notably in the two locations of  study. The findings
of this study also showed significant association
(P<0.05) between enteroviral infection and clinical
history of  subjects. In keeping with others19,32,41-43,
this study found frequency of enteroviral infections
to be higher among subjects with DCM (63.4%)
than hypertensives (40.0%) and HHF(25.0%),
supporting a causative association in adults.
Frequencies of the individual viruses have been highly
variable. The differences in the frequency of
occurrences of these isolates were also reported by
previous studies14,23,36,43-46.
Our findings are comparable to that of
Ferreira et al.29 and Fujioka et al.45 who isolated
enteroviruses; Coxsackie-B-viruses and echovirus-1
from DCM patients. All these previous reports and
our present findings support the enteroviral
involvement (especially group B and group A
Coxsackieviruses) in the aetiology of  DCM and
HHF11-13,29-31. Wojnicz et al.47 reported that 18(40.0%)
among patients with left ventricle (LV) dysfunction
demonstrated nonreplicative enterovirus. Wojnicz et
al.47 also reported that 10(56.0%) out of 18 patients
with left ventricle (LV) dysfunction were found to
have active viral replication. Why et al.32 reported
34.0% prevalence of enteroviral infection among
patients with idiopathic dilated cardiomyopathy
(IDCM). A recent cross-sectional study has reported
a much higher frequency of positive PCR for one
or more viruses in patients with idiopathic LV
dysfunction21 or LV diastolic dysfunction in the
absence of myocarditis22.
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Conclusion
The higher frequency of echoviruses and Coxsackie-
B5-viruses as well as the presence of other enteroviral
serotypes in this study suggest the possible association
of  these viruses in the etiology of  HHF and DCM
patients as have been previously reported by earlier
workers. Attention must be directed toward currently
recognized cardiotropic viruses and remain alert to
the possibility that other viruses are common cardiac
pathogens. Thus, this study further confirms the
continued circulation of NPEV among
hypertensives, HHF and DCM patients in Nigeria.
Acknowledgement
Our deep and sincere gratitude goes to all those who
voluntarily participated in this study. The authors
would like to thank management and staff  of  World
Health Organization Regional Reference Laboratory
for Polio, Department of  Virology, College of
Medicine, University of Ibadan for their support
throughout the period of  this study. Our gratitude
also goes to the management and staff of
Cardiology Unit, Department of  Medicine, College
of Medicine, University of Ibadan for their support
throughout the period of  this study. The support
of  the management and staff  of  Cardiology Unit,
Department of  Medicine, Federal Medical Centre,
Abeokuta were also acknowledged. The excellent
technical assistance of  Dr. OG Oyero, Dr. MO
Adewumi, Dr. Ochulor, Dr. (Mrs.) Enakpene, Dr.
Bola Oyemankinde, Mr. E. Donbraye, Mr. O.
Abidemi, Mr. Adeyemi, Mrs. OA Akanbi, Mrs
Olufunke Oyero, Miss Olusola Oyetunde, Miss
Olufunke Adewale, Mr. Tope Ogundiran and Mr.
Oluwaseun Adedeji is sincerely acknowledged.
References
1. Melnick JL. Enteroviruses: Polioviruses,
coxsackieviruses, echoviruses and newer
enteroviruses in: Fields virology. Fields BN,
Knipe DM, Melnick JL, Chanock RM,
Roizmann B, Shope RE (Ed.) New York: Raven
press. 1985, 739-794
2. Modlin JF. Coxsackiviruses, echoviruses and
newer enteroviruses in: Principles and practice
of  infectious diseases. Mandel GL, Bennett JE,
Dolin R (Ed.). New York: Churchill Livingstone.
1995, 1620-1636
3. Falase AO, Fabiyi A, Odegbo-Olukoya OO.
Coxsackie B viruses and heart muscle diseases
in Nigerian adults. Trop. Geog. Med 1978; 31; 237-
243.
4. Falase AO, Sekoni GA, Adenle AD. Dilated
cardiomyopathy in young adult Africans, sequel
to infections? African Journal of  Medical Science
1982; 11: 1-5
5. Yoon JW. The roll of  viruses and environmental
factors in the induction of  diabetes. Carr. Top
Environ. Microbiology 1990; 164: 95-123
6. Shariff Mk, Hemtages R and Ciard M.
Intrathecal Immune response in patients with the
post-poliosyndrome. New England Journal of
Medicine 1991; 325: 749-755.
7. Woodal CJ, Riding MH and Clements GB.
Sequences specific for enteroviruses detected in
spiral cord from patients with motor neurone
disease. British Medical Journal 1994; 308; 1541-
1543
8. Clements Gb, Mcgarry F, Naim C. et al. The
detection of enterovirus specific RNA in serum
the relationship to chronic fatique. J. Med. Virol
1995; 45: 151-166
9. Pallansch MA, Roos RP. Enteroviruses:
polioviruses, coxsackieviruses, echoviruses, and
newer enteroviruses. In: Knipe Dm, Howley PM,
Griffin DE, Lamb RA, Martin MA, Riozman
B, Straus SE, editors. Fields virology. 4th ed.
Philadelphia: Lippincott Williams & Wilkins,
2001; p723-775.
10. Baboonian C, Davies MJ, Booth JC, McKenna
WJ. Coxsackie B viruses and human heart disease.
Curr Top Microbiol Immunol 1997; 223:31–52.
11. Li Y, T Peng, Y Yang, C Niu, L Archard, and H
Zhang. High prevalence of  enteroviral genomic
sequences in myocardium from cases of
endemic cardiomyopathy (Keshan disease) in
China. Heart 2000; 83(6): 696–701.
12. Andreoletti L, Bourlet T, Moukassa D, Rey L,
Hot D, Li Y, Lambert V, et al. Enteroviruses
can persist with or without active viral replication
in cardiac tissue of patients with end-stage
ischemic or dilated cardiomyopathy. J. Infect. Dis
2000; 182 (4), 1222–1227.
13. Chapman NM, KS Kim, KM Drescher, K Oka,
S Tracy. 52  terminal deletions in the genome of
a coxsackievirus B2 strain occurred naturally in
human heart. Virology, 2008 (in press) YVIRO-
04622; No. of  pages: 12; 4C: 2
14. Magnani JW, Dec GW. Myocarditis: current
trends in diagnosis and treatment. Circulation
2006; 113: 876–890.
African Health Sciences Vol 13  Issue 4 December  2013 1105
15. Heymans S. Myocarditis and heart failure: need
for better diagnostic, predictive, and therapeutic
tools. European Heart Journal 2007;  28(11):1279-
1280
16. Mahrholdt H, Wagner A, Deluigi CC, Kispert
E, Hager S, Meinhardt G, et al. Presentation,
patterns of myocardial damage, and clinical
course of  viral myocarditis. Circulation 2006;
114:1581–1590.
17. Heymans S, Pauschinger M, De Palma A,
Kallwellis-Opara A, Rutschow S, Swinnen M,
et al. Inhibition of urokinase-type plasminogen
activator or matrix metalloproteinases prevents
cardiac injury and dysfunction during viral
myocarditis. Circulation 2006; 114:565–573.
18. Maekawa Y, Ouzounian M, Opavsky MA, Liu
PP. Connecting the missing link between dilated
cardiomyopathy and viral myocarditis: virus,
cytoskeleton, and innate immunity. Circulation,
2007; 115:5–8.
19. Caforio ALP, Calabrese F, Angelini A, Tona F,
Vinci A, Bottaro S, Ramondo A, et al. A
prospective study of biopsy-proven
myocarditis: prognostic relevance of clinical and
aetiopathogenetic features at diagnosis. Eur Heart
Journal 2007; 28:1326–1333.
20. Pauschinger M, Doerner A, Kuehl U,
Schwimmbeck PL, Poller W, Kandolf  R,
Schultheiss HP.  Enteroviral RNA replication in
the myocardium of patients with left ventricular
dysfunction and clinically suspected myocarditis.
Circulation 1999; 99: 889–895.
21. Kuhl U, Pauschinger M, Seeberg B, Lassner D,
Noutsias M, Poller W, Schultheiss HP. Viral
persistence in the myocardium is associated with
progressive cardiac dysfunction. Circulation
2005a; 112:1965–1970.
22. Tschöpe C, Bock CT, Kasner M, Noutsias M,
Westermann D, Schwimmbeck PL, et al. Heart
Failure-High Prevalence of  Cardiac Parvovirus
B19 Infection in Patients With Isolated Left
Ventricular Diastolic Dysfunction. Circulation
2005; 111:879-886.
23. Kuhl U, Pauschinger M, Noutsias M, Seeberg
B, Bock T, Lassner D, Poller W, Kandolf  R,
Schultheiss HP. High prevalence of  viral genomes
and multiple viral infections in the myocardium
of adults with ‘idiopathic’ left ventricular
dysfunction. Circulation 2005b; 111:887–893.
24. Schiff GM, Sherwood JR. Clinical activity of
pleconaril in an experimentally induced
coxsackievirus A21 respiratory infection. J. Infect.
Dis 2000; 181:20–26.
25. Romero JR. Pleconaril: a novel antipicornaviral
drug. Expert Opin. Investig. Drugs 2001; 10:369–
379.
26. Rotbart HA, Webster AD. Treatment of
potentially life threatening enterovirus infections
with pleconaril. Clin. Infect. Dis 2001; 32:228–
235.
27. Elfaitouri A, Nahla M, Jan Fohlman RA,  Gun
F, Go¨ran F, Lars M, Jonas B. Quantitative PCR-
Enhanced Immunoassay for Measurement of
Enteroviral Immunoglobulin M Antibody and
Diagnosis of  Aseptic Meningitis. Clinical and
Diagnostic Laboratory Immunology 2005; 12(2): 235–
241
28. World Health Organization (WHO). Manual for
the Virological Investigation of  Poliomyelitis.
Geneva, Switzerland: World Health
Organization, 2004.
29. Ferreira Junior AG, Ferreira SMAG, Gomes
MLC, Linhares ACT. Enteroviruses as a possible
cause of myocarditis, pericarditis and dilated
cardiomyopathy in Belum, Brazil. Brazilian
Journal of Med. Biol. Res 1995; 28(8):869-874.
30. Muir P, F Nicholson, SJ Illavia, TS McNeil, JF
Ajetunmobi, H Dunn, WG Starkey, KN Reetoo,
N RB Cary, J Parameshwar, JE Banatvala.
Serological and molecular evidence of
enterovirus infection in patients with end-stage
dilated cardiomyopathy. Heart 1996;76:243-249
31. Rey L, Valérie Lambert, Pierre Wattré, Laurent
Andréoletti. Detection of enteroviruses
ribonucleic acid sequences in endomyocardial
tissue from adult patients with chronic dilated
cardiomyopathy by a rapid RT-PCR and
hybridization assay. Journal of  Medical Virology
2001; 64(2): 133–140
32. Why HJ, Meany BT, Richardson PJ, Olsen EG,
Bowles NE, Cunningham L, Freeke CA,
Archard LC. Clinical and prognostic significance
of detection of enteroviral RNA in the
myocardium of patients with myocarditis or
dilated cardiomyopathy. Circulation 1994; 89:
2582–2589.
33. Omonayajo TB. Isolation and Identification of
Enteroviruses in Non-Polio AFP in Nigeria. An
M.Sc. Project in the Dept. of  Virology,
University of Ibadan, Nigeria, 2002; 96p
34. Honeyman, M. How robust is the evidence for
viruses in the induction of type 1 diabetes?
Current Opinion Immunology 2005; 17(6): 616-623.
35. Ajabaluku OV. Isolation of  Coxsackieviruses
from Hypertensive Patients with Heart Failure.
African Health Sciences Vol 13  Issue 4 December  20131106
An M.Sc. Project in the Dept. of  Virology.
University of Ibadan, Nigeria, 2006; 81p
36. Adejokun AT. Isolation of  Enteroviruses in
Patients Presenting with Dilated
Cardiomyopathy. An M.Sc. Project in the Dept.
of  Virology. University of  Ibadan, Nigeria 2006;
77p
37. Skarsvik S, Puranen J, Honkanen J. Decreased in
vitro type 1 immune response against coxsackie
virus B4 in children with type 1 diabetes. Diabetes
2006; 55(4): 996-1003.
38. Trallero G, Casas I, Tenorio A, Echevarria JE,
Castellanos A, Lozano A, Brena PP.
Enteroviruses in Spain: virological and
epidemiological studies over 10 years (1988-97).
Epidemiol Infect 2000; 124(3):497-506.
39. Wenner HA, Abel D, Olson LC, Burry VF.
A mixed epidemic associated with echoviruses
types 6 and 11. Virologic clinical and
epidemiologic studies. Am J Epidem 1981;
114:369-378
40. Antia AU, Cockshott WP, Thorpe GJ. Idiopathic
cardiomegaly in Nigeria Children. British Heart
Journal 1969; 2:178-183.
41. Figulla HR, Stille-Siegerer M, Mall G, Heim A,
Kreuzer H. Myocardial enterovirus infection with
left ventricular dysfunction: a benign disease
compared with idiopathic dilated
cardiomyopathy. J. Am. Coll. Cardiol 1995;
25:1170–1175.
42. Grumbach IM, Heim A, Pring-Akerblom I,
Vonhof  S, Hein WJ, Muller G, Figulla HR.
Adenoviruses and enteroviruses as pathogens in
myocarditis and dilated cardiomyopathy. Acta
Cardiol 1999; 54:83–88.
43. Frustaci A, Chimenti C, Calabrese F, Pieroni M,
Thiene G, Maseri A. Immunosuppressive
therapy for active lymphocytic myocarditis:
virological and immunologic profile of
responders versus nonresponders. Circulation
2003; 107: 857–863.
44. Fujioka S, Koide H, Kitaura Y, Duguchi H,
Kawamura K. Coxsackieviruses B pathogenic
role in progression of  dilated cardiomyopathy.
Am. Heart J 1995; 131 (4):760-765
45. Fujioka S, Kitaura A, Deguchi H, Kawamura
K, Isomura T, Suma H, Shimizu A. Evaluation
of viral infection in the myocardium of patients
with idiopathic dilated cardiomyopathy. J. Am.
Coll. Cardiol 2000; 36:1920–1926.
46. Bowles NE, Bowles NE, Ni J, Kearney DL,
Pauschinger M, Schultheiss HP, McCarthy R, et
al. Detection of viruses in myocardial tissues by
polymerase chain reaction: evidence of
adenovirus as a common cause of myocarditis
in children and adults. J. Am. Coll. Cardiol 2003;
42:466–472
47. Wojnicz R, Nowalany-Kozielska E,
Wojciechowska C, Glanowska G, Wilczewski
P, Niklewski T, et al. Randomized, placebo-
controlled study for immunosuppressive
treatment of inflammatory dilated
cardiomyopathy: two-year follow-up results.
Circulation 2001; 104:39–45.
